Jonathan R Adkins

Summary

Publications

  1. ncbi Mammography as screening for coronary artery disease
    Jonathan R Adkins
    Department of Surgery, Mercer University School of Medicine, Medical Center of Central Georgia, Macon, Georgia, USA
    Am Surg 73:717-21. 2007
  2. ncbi Norepinephrine is a more potent inhibitor of tumor necrosis factor over a range of doses than dopamine
    Joe Harris Morgan
    Department of Surgery, Medical Center of Central Georgia, Mercer University School of Medicine, Macon, Georgia 31201, USA
    Am Surg 70:526-8. 2004
  3. ncbi Rapamycin inhibits release of tumor necrosis factor-alpha from human vascular smooth muscle cells
    Jonathan R Adkins
    Department of Surgery, Mercer University School of Medicine, Macon, Georgia, USA
    Am Surg 70:384-7; discussion 387-8. 2004

Collaborators

  • Paul S Dale
  • Joe Harris Morgan
  • Joshua R Groves
  • T Clark Gamblin
  • Martin L Dalton
  • Dennis W Ashley

Detail Information

Publications3

  1. ncbi Mammography as screening for coronary artery disease
    Jonathan R Adkins
    Department of Surgery, Mercer University School of Medicine, Medical Center of Central Georgia, Macon, Georgia, USA
    Am Surg 73:717-21. 2007
    ..Perhaps women with BAC seen on screening mammography should undergo further workup for CAD, with the potential benefit of early intervention...
  2. ncbi Norepinephrine is a more potent inhibitor of tumor necrosis factor over a range of doses than dopamine
    Joe Harris Morgan
    Department of Surgery, Medical Center of Central Georgia, Mercer University School of Medicine, Macon, Georgia 31201, USA
    Am Surg 70:526-8. 2004
    ..This is a statistically significant linear trend (P < .0001). Both norepinephrine and dopamine are powerful anti-inflammatory agents. Norepinephrine is a more potent inhibitor of TNF than dopamine...
  3. ncbi Rapamycin inhibits release of tumor necrosis factor-alpha from human vascular smooth muscle cells
    Jonathan R Adkins
    Department of Surgery, Mercer University School of Medicine, Macon, Georgia, USA
    Am Surg 70:384-7; discussion 387-8. 2004
    ..g., isoproterenol). Therefore, a potential mechanism for the effectiveness of rapamycin-releasing stents is reduction of inflammatory cytokine expression by VSMCs...